Literature DB >> 16713690

Microprocessor controlled transdermal drug delivery.

J Anand Subramony1, Ashutosh Sharma, J B Phipps.   

Abstract

Transdermal drug delivery via iontophoresis is reviewed with special focus on the delivery of lidocaine for local anesthesia and fentanyl for patient controlled acute therapy such as postoperative pain. The role of the microprocessor controller in achieving dosimetry, alternating/reverse polarity, pre-programmed, and sensor-based delivery is highlighted. Unique features such as the use of tactile signaling, telemetry control, and pulsatile waveforms in iontophoretic drug delivery are described briefly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713690     DOI: 10.1016/j.ijpharm.2006.03.053

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Microsecond thermal ablation of skin for transdermal drug delivery.

Authors:  Jeong Woo Lee; Priya Gadiraju; Jung-Hwan Park; Mark G Allen; Mark R Prausnitz
Journal:  J Control Release       Date:  2011-05-17       Impact factor: 9.776

Review 2.  Transdermal drug delivery.

Authors:  Mark R Prausnitz; Robert Langer
Journal:  Nat Biotechnol       Date:  2008-11       Impact factor: 54.908

3.  Microprocessor in controlled transdermal drug delivery of anti-cancer drugs.

Authors:  N S Chandrashekar; R H Shobha Rani
Journal:  J Mater Sci Mater Med       Date:  2008-07-01       Impact factor: 3.896

Review 4.  Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress.

Authors:  Yu Wang; Lijuan Zeng; Wenting Song; Jianping Liu
Journal:  Drug Deliv Transl Res       Date:  2021-01-23       Impact factor: 4.617

5.  Ionic liquids as effective additives to enhance the solubility and permeation for puerarin and ferulic acid.

Authors:  Jing Yuan; Ningning Zhou; Jieyu Wu; Tianxiang Yin; Yunbin Jia
Journal:  RSC Adv       Date:  2022-01-26       Impact factor: 3.361

Review 6.  Iontophoresis of Biological Macromolecular Drugs.

Authors:  Mahadi Hasan; Anowara Khatun; Kentaro Kogure
Journal:  Pharmaceutics       Date:  2022-02-26       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.